Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “R-CHOP Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04566887
What this trial is testing

Acalabrutinib With R-CHOP in Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
University Health Network, Toronto 105
Not applicableStudy completedNCT05350930
What this trial is testing

Multidisciplinary Care Program to Secure MEdication Therapy for HematoLOgy Patients Receiving Injectable Anticancer Drugs

Who this might be right for
Chemotherapy EffectG-CHOP ChemotherapyR-CHOP Chemotherapy
Hospices Civils de Lyon 38
Testing effectiveness (Phase 2)UnknownNCT00722930
What this trial is testing

Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas 38
Testing effectiveness (Phase 2)UnknownNCT01181999
What this trial is testing

Rituximab Augmentation Following R-CHOP Induction Chemotherapy in Extremely Elderly Patients With Diffuse Large B Cell Lymphoma

Who this might be right for
Lymphoma, Large B-cell, Diffuse
Chonnam National University Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT00450385
What this trial is testing

Genes in Predicting Outcome of Patients With DLBCL Treated With Rituximab and Combination Chemotherapy (R-CHOP)

Who this might be right for
Lymphoma
University of Miami 57
Not applicableWithdrawnNCT01843868
What this trial is testing

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Who this might be right for
Lymphoma, Non-Hodgkin
Australasian Leukaemia and Lymphoma Group
Large-scale testing (Phase 3)Active Not RecruitingNCT06356129
What this trial is testing

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
Celgene 850
Testing effectiveness (Phase 2)Study completedNCT04263584
What this trial is testing

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
University Hospital Muenster 62
Early research (Phase 1)Not Yet RecruitingNCT07444710
What this trial is testing

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

Who this might be right for
Ann Arbor Stage II Mantle Cell LymphomaAnn Arbor Stage III Mantle Cell LymphomaAnn Arbor Stage IV Mantle Cell Lymphoma
National Cancer Institute (NCI) 16
Large-scale testing (Phase 3)Study completedNCT02285062
What this trial is testing

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Celgene 570
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07702851
What this trial is testing

Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP

Who this might be right for
Diffuse Large B-cell Lymphoma
Yonsei University 47
Large-scale testing (Phase 3)Ended earlyNCT00486759
What this trial is testing

Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Hoffmann-La Roche 787
Testing effectiveness (Phase 2)Study completedNCT00169468
What this trial is testing

Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma

Who this might be right for
B Cell Lymphoma
Lymphoma Study Association 48
Large-scale testing (Phase 3)UnknownNCT00209209
What this trial is testing

Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL

Who this might be right for
Lymphoma, Mantle-Cell
European Mantle Cell Lymphoma Network 570
Testing effectiveness (Phase 2)Ended earlyNCT00088881
What this trial is testing

Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+5 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT00058422
What this trial is testing

Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 65
Large-scale testing (Phase 3)Looking for participantsNCT06091865
What this trial is testing

Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)
Regeneron Pharmaceuticals 904
Testing effectiveness (Phase 2)Study completedNCT00283439
What this trial is testing

A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma

Who this might be right for
Chemotherapy-Induced ThrombocytopeniaHodgkin's LymphomaNon-Hodgkin's Lymphoma+3 more
Amgen 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT03995147
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for Patients With Untreated B Cell Lymphoma

Who this might be right for
B Cell LymphomaLymphomaLymphoma, B-Cell+2 more
University of Chicago 51
Very early researchEnded earlyNCT00736450
What this trial is testing

Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage I Adult Diffuse Large Cell Lymphoma+2 more
University of Nebraska 37
Next Page